Brightside Health raised $33M in a strategic Series C led by S32 to fuel its growth into new markets and new offerings.

Mar 26, 2024•over 1 year ago

Amount Raised

$33 Million

Round Type

series c

San FranciscoHealth Care

Investors

TriventuresMousse PartnersAcmeAnne WojcickiTime Bio VenturesKennedy LewisS32

Description

Brightside Health announced a $33-million strategic Series C raise led by S32, with participation from Kennedy Lewis, Time BioVentures, Anne Wojcicki, ACME, Mousse Partners, and Triventures. The raise will be used to fuel Brightside Health’s growth into new markets and new offerings, especially to expand with Medicare, Medicaid, and other underserved populations, and to deliver measurably better outcomes.

Company Information

Company

Brightside Health, Inc.

Location

2471 Peralta Street

San Francisco, California, United States

About

Brightside Health delivers life-saving mental health care to people with mild to severe clinical depression, anxiety, and other mood disorders, including those with elevated suicide risk. Powered by proprietary AI, purpose-built technology, and a world-class clinician network, Brightside Health combines precision psychiatry and leading-edge therapeutic techniques to improve patient outcomes across the entire clinical spectrum, affordably and at scale. Brightside Health can be paid for with insurance in all 50 states and D.C., with appointments available in 48 hours or less.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends